NeuroPointDX has validated 12 metabolic subtypes of autism spectrum disorder. The diagnostic blood test for ASD will be
In collaboration with the Greater Madison Chamber of Commerce, the Wisconsin State Journal produced a special section to
Stemina Biomarker Discovery Prepares to Commercialize Autism Diagnostic Products; Appoints New Board Member, Heiner Dreismann, PhD, Former Head of Roche Molecular Diagnostics
Dr. Driesmann, a leader in the diagnostics industry, will guide Stemina’s commercialization strategy. Read the full press release.